In the last trading session, 1.03 million Acelyrin Inc (NASDAQ:SLRN) shares changed hands as the company’s beta touched 1.16. With the company’s per share price at $2.45 changed hands at $0.27 or 12.39% during last session, the market valuation stood at $247.23M. SLRN’s last price was a discount, traded about -195.92% off its 52-week high of $7.25. The share price had its 52-week low at $1.85, which suggests the last value was 24.49% up since then. When we look at Acelyrin Inc’s average trading volume, we note the 10-day average is 0.66 million shares, with the 3-month average coming to 1.91 million.
Analysts gave the Acelyrin Inc (SLRN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 14 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 5 recommended SLRN as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight. Acelyrin Inc’s EPS for the current quarter is expected to be -0.95.
Acelyrin Inc (NASDAQ:SLRN) trade information
Instantly SLRN was in green as seen at the end of in last trading. With action 4.70%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -21.97%, with the 5-day performance at 4.70% in the green. However, in the 30-day time frame, Acelyrin Inc (NASDAQ:SLRN) is -5.77% down. Looking at the short shares, we see there were 3.69 million shares sold at short interest cover period of 3.82 days.
The consensus price target for the stock as assigned by Wall Street analysts is 10.5, meaning bulls need an upside of 76.67% from its current market value. According to analyst projections, SLRN’s forecast low is 6 with 15 as the target high. To hit the forecast high, the stock’s price needs a -512.24% plunge from its current level, while the stock would need to soar -144.9% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2025 estimates are for Acelyrin Inc earnings to increase by 40.53%.
SLRN Dividends
Acelyrin Inc is expected to release its next quarterly earnings report on 2025-Mar-18.
Acelyrin Inc (NASDAQ:SLRN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 7.14% of Acelyrin Inc shares while 105.50% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 113.61%. There are 105.50% institutions holding the Acelyrin Inc stock share, with AYURMAYA CAPITAL MANAGEMENT COMPANY, LP the top institutional holder. As of 2024-06-30, the company held 9.4136% of the shares, roughly 9.33 million SLRN shares worth $41.17 million.
CITADEL ADVISORS LLC holds the second largest percentage of outstanding shares, with 7.4732% or 7.41 million shares worth $32.68 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were T. Rowe Price Small-Cap Stock Fund, Inc. and T. Rowe Price Small-Cap Value Fund, Inc. . With 3.63 shares estimated at $8.88 million under it, the former controlled 3.59% of total outstanding shares. On the other hand, T. Rowe Price Small-Cap Value Fund, Inc. held about 2.81% of the shares, roughly 2.84 shares worth around $6.95 million.
